In a groundbreaking announcement, Safety Shot Inc has unveiled plans for the direct-to-consumer launch of “Safety Shot,” a patented beverage set to revolutionize post-drinking recovery. Safety Shot is being hailed as the world’s first beverage designed to expedite the process of reducing blood alcohol content and enhancing mental clarity. This groundbreaking launch has sent ripples through the financial markets, leading to a substantial surge in the stock value of Safety Shot.
At the time of this publication, Safety Shot Inc stock (SHOT) has witnessed a surge.
Safety Shot Inc
Current Price: $1.45
Change : +0.28
Change (%): (23.50%)
Volume: 2.0M
Source: Tomorrow Events Market Data
The product is scheduled for release in the first week of December 2023 and will be available for retail purchase on the company’s official website, www.DrinkSafetyShot.com, and on Amazon.com. Additionally, the company has outlined its strategy to introduce business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024.
Safety Shot’s debut is bolstered by the strategic collaboration with Advantage Solutions, a leading provider of sales, marketing, and technology solutions. Advantage Solutions, with a formidable portfolio of clients including industry giants like Anheuser-Busch, Spindrift, and Keurig/Dr. Pepper, as well as major retail chains like Costco, Target, Walmart, Kroger, and Albertsons, possesses an impressive track record in managing over $80 billion in annual sales across 250,000 retail outlets spanning 35 countries.
Safety Shot is poised to redefine the boundaries of innovation and wellness by creating a new product category within the rapidly expanding $1.56 billion market for hangover remedies, which is projected to grow by 14.6% from 2021 to 2028.
What sets Safety Shot apart is its revolutionary patented formula, which expedites the body’s detoxification process by harnessing a specific blend of all-natural vitamins, minerals, and nootropics to facilitate rehydration and mental clarity. The beverage operates through four distinct mechanisms of action, targeting the central nervous system and addressing the impairments caused by alcohol consumption:
1. Sobering up the individual.
2. Preventing further absorption of residual alcohol in the gut.
3. Reducing the effects of already-absorbed alcohol in the bloodstream.
4. Maintaining proper hydration.
Moreover, Safety Shot incorporates a fifth component that no other beverage or remedy can claim: improving the mental and physical sense of wellbeing.
Recent research conducted on the nutraceutical functional beverage version of Safety Shot, set to launch in December, showed remarkable results. It reduced blood alcohol content (BAC) within just 30 minutes. The average reduction in BAC percentage was 0.079% per hour for the group that consumed Safety Shot, compared to a mere 0.01% BAC per hour for the control group that did not. The findings were statistically significant, with a p-value of 0.02428. A more comprehensive, double-blinded, placebo-controlled trial is currently underway, and the results are expected in December 2023. Additionally, a concentrated, prescription version of the Safety Shot formula is under development for alcohol poisoning detox.
Safety Shot’s CEO, Brian John, expressed enthusiasm about the product’s launch and its multi-channel strategy aimed at dominating the e-commerce landscape, securing retail shelf space, and forming robust partnerships with distribution and sales associates. With an executive team that has previously launched successful brands and achieved billions in sales at prominent companies such as Anheuser-Busch, and the unwavering support of Advantage Solutions and an expanding roster of influential brand ambassadors, Safety Shot Inc. is poised to introduce a game-changing product that is set to carve out a new niche within the beverage industry.
